Find NINDS Clinical Trials

Find NINDS Clinical Trials

Subscribe to Find NINDS Clinical TrialsRSS
Filter By:
Returning 76 results
Study Titlesort ascending Location Status Disorders
Anakinra for the Treatment of Chronically Inflamed White Matter Lesions in Multiple Sclerosis Maryland* Not Yet Recruiting Multiple Sclerosis
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) Multiple U.S. Locations Recruiting FTLD, Progressive Supranuclear Palsy (PSP), Frontotemporal Dementia (FTD), Corticobasal Degeneration (CBD), PPA Syndrome, Behavioral Variant Frontotemporal Dementia (bvFTD), Semantic Variant Primary Progressive Aphasia (svPPA), Nonfluent Variant Primary Progressive Aphasia (nfvPPA), FTD With Amyotrophic Lateral Sclerosis (FTD/ALS), Amyotrophic Lateral Sclerosis (ALS), Oligosymptomatic PSP (oPSP), Corticobasal Syndrome (CBS)
A Model to Identify Specific Predictors of Spatial Neglect Recovery Multiple U.S. Locations Active, Not Recruiting Spatial Neglect, Hemispatial Neglect, Hemineglect, Unilateral Neglect, Visual Spatial Neglect, Sensory Neglect
A Comparison of an Implanted Neuroprosthesis With Sensory Training for Improving Airway Protection in Chronic Dysphagia Maryland* Completed Chronic Dysphagia, Multiple Sclerosis, Parkinson Disease
A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Multiple U.S. Locations Completed Relapsing Remitting Multiple Sclerosis
A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients Maryland Completed Multiple Sclerosis

Pages